Prescription Drug Monitoring Program – Dispensers – Veterinarians
Impact
The adjustment in the definition of dispenser will enable veterinarians to participate more fully in the state's controlled substances monitoring efforts. By including them in the PDMP, the bill aims to ensure that the dispensing of medications for animals is conducted responsibly, helping to combat misuse and abuse of prescription drugs. This change could lead to better tracking and regulation, which is particularly important given the rise in opioid prescriptions and concerns over their potential for abuse.
Summary
House Bill 57 is an act that amends the existing legislation surrounding the Prescription Drug Monitoring Program (PDMP) in Maryland. The key focus of the bill is to expand the definition of 'dispenser' to include licensed veterinarians who dispense controlled substances in the course of their professional services. This change recognizes the critical role veterinarians play in prescribing and dispensing medications necessary for the treatment of animals, and it seeks to improve oversight of these practices.
Contention
While the bill is primarily seen as a positive step towards better management of drug prescriptions, there are concerns regarding the implications for data privacy. The legislation states that the PDMP is not required to disclose its monitoring data to veterinarians, which raises questions about transparency and the information available to practitioners. Some critics may argue that this lack of data access could hinder veterinarians' ability to make informed treatment decisions for their patients.
Overall_significance
HB57 reflects a broader trend towards acknowledging the importance of comprehensive medication monitoring across various fields of health care, including veterinary medicine. By integrating veterinarians into the PDMP framework, the state aims to create a more seamless system for monitoring prescription drugs, potentially leading to improved health outcomes for both animals and humans through better regulatory practices.
Requires prescriptions for animals to be issued in name of animal owner; prohibits unnamed persons from possessing prescribed drugs; and requires Prescription Monitoring Program to include information about controlled substances prescribed by veterinarians.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.